Logo image
Evidence that acetylsalicylic acid attenuates inflammation in the walls of human cerebral aneurysms: preliminary results
Journal article   Open access

Evidence that acetylsalicylic acid attenuates inflammation in the walls of human cerebral aneurysms: preliminary results

David M Hasan, Nohra Chalouhi, Pascal Jabbour, Aaron S Dumont, David K Kung, Vincent A Magnotta, William L Young, Tomoki Hashimoto, H Richard Winn and Donald Heistad
Journal of the American Heart Association, Vol.2(1), pp.e000019-n/a
02/22/2013
DOI: 10.1161/JAHA.112.000019
PMCID: PMC3603234
PMID: 23525414
url
https://doi.org/10.1161/JAHA.112.000019View
Published (Version of record) Open Access

Abstract

Inflammatory cells and molecules may play a critical role in formation and rupture of cerebral aneurysms. Recently, an epidemiologic study reported that acetylsalicylic acid (ASA) decreases the risk of aneurysm rupture. The goal of this study was to determine the effects of ASA on inflammatory cells and molecules in the walls of human cerebral aneurysms, using radiographic and histological techniques. Eleven prospectively enrolled patients harboring unruptured intracranial aneurysms were randomized into an ASA-treated (81 mg daily) group (n=6) and an untreated (control) group (n=5). Aneurysms were imaged at baseline using ferumoxytol-enhanced MRI to estimate uptake by macrophages. After 3 months, patients were reimaged before undergoing microsurgical clipping. Aneurysm tissues were collected for immunostaining with monoclonal antibodies for cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2), microsomal prostaglandin E2 synthase-1 (mPGES-1), and macrophages. A decrease in signal intensity on ferumoxytol-enhanced MRI was observed after 3 months of ASA treatment. Expression of COX-2 (but not COX-1), mPGES-1, and macrophages was lower in the ASA group than in the control group. This study provides preliminary radiographical and histological evidence that ASA may attenuate the inflammatory process in the walls of human cerebral aneurysms. URL: http://www.clinicaltrials.gov. Unique identifier: NCT01710072.
Immunohistochemistry Magnetic Resonance Imaging Prospective Studies Humans Middle Aged Male Tomography, X-Ray Computed Intracranial Aneurysm - diagnosis Cerebral Angiography - methods Angiography, Digital Subtraction Cerebral Arteries - drug effects Time Factors Inflammation - drug therapy Inflammation Mediators - metabolism Female Aspirin - therapeutic use Inflammation - diagnosis Intracranial Aneurysm - drug therapy Intramolecular Oxidoreductases - metabolism Macrophages - immunology Cerebral Arteries - immunology Treatment Outcome Inflammation - immunology Intracranial Aneurysm - surgery Intracranial Aneurysm - immunology Iowa Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Cerebral Arteries - metabolism Prostaglandin-E Synthases Cerebral Arteries - pathology Cyclooxygenase 2 - metabolism Macrophages - drug effects Aged Cyclooxygenase 1 - metabolism Inflammation - surgery

Details

Metrics

Logo image